Gut Feeling: Can microbes boost your mood?

By Caitlin Dow, PhD Published August 26, 2019 “It sounds a bit like science fiction, doesn’t it?” says Valerie Taylor, head of the department of psychiatry at the University of Calgary. She’s talking about evidence that microbes in your gut may influence your brain. For example: ■ Mice are anxious and prefer dark, enclosed spaces. But […]

UCalgary startup Taylored Biotherapeutics to commercialize psychobiotic therapies

By Microbiome Times Published December 2, 2024 Taylored Biotherapeutics, founded by UCalgary’s Dr. Valerie Taylor, MD, PhD, and supported by Chief Operating Officer Asem Bala, has achieved a significant milestone by securing a $100,000 grant from the Ontario Brain Institute (OBI). This award, part of OBI’s highly competitive Neurotech Entrepreneurship to Validate Emerging Innovations (NERVE) program, will support Taylored Biotherapeutics’ pioneering work in psychobiotic […]

Fecal transplants could ward off depression. Researchers have a pill for that

By Bill Kaufmann Published Aug 13, 2024 What might seem stomach-turning could prove a key to better mental health, say University of Calgary researchers. The scientists have embarked on a study to determine if fecal microbiota transplant (FMT) using so-called poop pills can reduce the effects of depression and obsessive-compulsive disorder (OCD). In a U of C lab, […]

Depression, Anxiety and Autism: Is the Answer in Your Poop?

The gut-brain connection is being researched more vigorously than ever. Dr. Valerie Taylor, an expert in psychiatry research and fecal transplant gives her opinion in this area. Hippocrates has been famously quoted, especially by the functional medicine and holistic doctors, that, “All illnesses begin in the gut.” Today’s podcast guest, Dr. Valerie Taylor may be […]

Gut Bacteria’s Role in Anxiety and Depression: It’s Not Just In Your Head

Mounting evidence shows that gut bacteria affect mental health. Experts are now testing psychobiotics as depression, anxiety and other mental health remedies. For decades, experts scoffed at the idea that gut bacteria affect our mental health. Many called it a fringe theory. Yet mounting evidence suggests that intestinal microbes profoundly shape our thinking and behavior. Human […]

Why the Future of Mental Health Care Could Be in Your Gut

Listen to Taylored CEO Dr Valerie Taylor speak to the Wall Street Journal on the gut brain axis. A growing body of research suggests that the gut microbiome, the bacteria and other organisms that live in the gut, is linked to our mental health. But what if doctors could act on that information to treat […]

Nurosene Enters Into Agreement With Taylored Biotherapeutics to Evaluate Clinical Trial Results

TORONTO, June 22, 2022 /CNW/ – Nurosene Health Inc. (“Nurosene” or the “Company”) (CSE: MEND) (Frankfurt: 8TV) (OTC: MNNDF), a healthtech company focused on delivering innovative AI-based technology solutions for mental performance and wellness, enters into a Master Service Agreement with Taylored Biotherapeutics (“Taylored”), an early-stage biotechnology company focused on developing safe and effective microbial based therapies, or […]

Receive the latest news

Join Our Journey

Be the First to Know: Unlock exclusive updates on the progress and launch timeline of our groundbreaking biotherapeutics product development.

Name(Required)

Asem Bala

MSc

Asem Bala, MSc has over 20 years of experience in Healthcare & Clinical Research Management, now working at Taylored Biotherapeutics to create partnerships and ensure regulatory approvals.

Dr. Valerie Taylor

MD, PhD, FRCP

Dr. Valerie Taylor, MD, PhD, FRCP is a Professor of Psychiatry at the University of Calgary. She completed a Bachelor of Medical Science and graduated from medical school at Memorial University of Newfoundland. She subsequently finished her residency training in Psychiatry and got her PhD in Neuroscience from McMaster University in Hamilton, Ontario. Prior to coming to Calgary, she was the chief of Psychiatry at the Women’s College Hospital and the chief of Adult Health Services at the Center for Addiction and Mental Health in Toronto.

Her academic focus has been on the area of medical psychiatry – specifically, for the last 5 years, on the gut brain axis and the the gut microbiome. She is the only funded researcher in North America examining the therapeutic effects of fecal transplant as a treatment for mental health and she currently has 4 novel clinical trials looking at modifying the gut microbiome to treat mood disorders as well as the largest biological neuroscience microbiome repository in North America. She has over 180 peer reviewed publications and funding from a variety of national and international funding agencies. In 2020 she started Taylored Biotherapeutics, a micro therapeutics drug company. Today her primary role is in leading product development, getting regulatory approval, and finding partnerships.